Centre hospitalier de l'Université de Montréal

Montreal, Quebec H2X2P1

16 studies enrolling now · 45 studies all time

What they study most

Acute Coronary Syndrome, Acute Kidney Injury, Aortic Stenosis, Atrial Fibrillation, Bleeding, Breast Cancer, Breast Cancer Recurrent, Breast Neoplasms, COVID-19, COVID-19 Disease, Cancer Neck, Cancer of the Prostate

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. — Recruiting now
• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) — Recruiting now
• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
• Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. — Recruiting now
• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now
• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress — Recruiting now
• Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement — Recruiting now
• Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery — Recruiting now
• Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) — Running, not enrolling
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling
• WATER IV Prostate Cancer — Running, not enrolling
• 10°C vs 4°C Lung Preservation RCT — Running, not enrolling
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma — Running, not enrolling
• Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease — Starting soon
• Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults — Stopped early
• Long Term Follow Up for CTSN Mitral Valve Repair Studies — Running, not enrolling
• A Study of LY2880070 in Participants With Advanced or Metastatic Cancer — Completed
• Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer — Running, not enrolling
• Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer — Stopped early
• TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3) — Running, not enrolling
• SCRIPT: Sickle Cell Risk in Pregnancy Tool — Enrolling by invitation
• Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. — Completed
• SAHaRA: A Randomized Controlled Trial — Completed
• Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults — Completed
• Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery — Completed
• Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury — Completed
• OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone — Stopped early
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early
• A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2) — Completed
• LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer — Completed
• DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial — Completed
• Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation — Completed
• Transfusion Requirements in Cardiac Surgery III — Completed
• Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1) — Completed
• Topical Infliximab in Autoimmune Eyes With Keratoprosthesis — Withdrawn before enrolling